Monoamine Oxidase Type B Inhibitor class drugs
3 results
Selegiline hydrochloride (selegiline hydrochloride)
(Selegiline Hydrochloride)Novitium Pharma LLC
Usage: Selegiline hydrochloride capsules are indicated as an adjunct to levodopa/carbidopa in Parkinsonian patients experiencing diminished response quality. It has shown significant benefits in managing symptoms when combined with levodopa therapy, including reduced 'off' time and improved treatment success measures. No benefit exists without concurrent levodopa.
Selegiline hydrochloride (selegiline hydrochloride)
(Selegiline Hydrochloride)A2A Integrated Pharmaceuticals
Usage: Selegiline Hydrochloride Tablets are indicated as an adjunct treatment for Parkinson's patients experiencing deterioration while on levodopa/carbidopa. It has shown benefits in reducing "off" time and improving overall treatment success, including mobility and daily functioning, only when used with levodopa therapy.
Xadago (safinamide mesylate)
(safinamide mesylate)MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.
Usage: XADAGO is indicated as an adjunctive treatment for patients with Parkinson's disease who are experiencing "off" episodes while on levodopa/carbidopa therapy.